Veris Residential (NYSE:VRE – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided EPS guidance of 0.610-0.630 for the period, compared to the consensus EPS estimate of 0.600. The company issued revenue guidance of -.
Veris Residential Price Performance
VRE stock opened at $16.22 on Wednesday. The company has a market cap of $1.51 billion, a price-to-earnings ratio of -95.38, a PEG ratio of 2.50 and a beta of 1.27. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 1.34. The firm has a 50 day moving average of $16.06 and a 200-day moving average of $16.97. Veris Residential has a 12-month low of $13.84 and a 12-month high of $18.85.
Veris Residential (NYSE:VRE – Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $68.08 million for the quarter, compared to analyst estimates of $66.98 million. Veris Residential had a negative return on equity of 4.97% and a negative net margin of 5.70%. As a group, equities analysts expect that Veris Residential will post 0.61 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on Veris Residential
About Veris Residential
Veris Residential, Inc is a forward-thinking, environmentally and socially conscious real estate investment trust (REIT) that primarily owns, operates, acquires and develops holistically-inspired, Class A multifamily properties that meet the sustainability-conscious lifestyle needs of today’s residents while seeking to positively impact the communities it serves and the planet at large.
See Also
- Five stocks we like better than Veris Residential
- Best Stocks Under $5.00
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
- The 3 Best Retail Stocks to Shop for in August
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
- What is a Death Cross in Stocks?
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Receive News & Ratings for Veris Residential Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veris Residential and related companies with MarketBeat.com's FREE daily email newsletter.